A share price of Hims & Hers Health Inc [HIMS] is currently trading at $38.4, up 3.53%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The HIMS shares have gain 7.17% over the last week, with a monthly amount drifted -18.51%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Needham downgraded its rating to Hold on June 23, 2025. On June 04, 2025, Needham reiterated its Buy rating and revised its price target to $65 on the stock. TD Cowen downgraded its rating to a Hold but stick to its price target of $30 on April 29, 2025. Morgan Stanley downgraded its rating to a Equal-Weight and raised its price target to $60 on February 18, 2025. Citigroup downgraded its rating to Sell for this stock on January 10, 2025, and upped its price target to $25. In a note dated January 07, 2025, BTIG Research initiated a Buy rating and provided a target price of $35 on this stock.
Hims & Hers Health Inc experienced fluctuations in its stock price throughout the past year between $23.97 and $72.98. Currently, Wall Street analysts expect the stock to reach $46.5 within the next 12 months. Hims & Hers Health Inc [NYSE: HIMS] shares were valued at $38.4 at the most recent close of the market. An investor can expect a potential return of 21.09% based on the average HIMS price forecast.
Analyzing the HIMS fundamentals
Trailing Twelve Months sales for Hims & Hers Health Inc [NYSE:HIMS] were 2.21B which represents 49.16% growth. Gross Profit Margin for this corporation currently stands at 0.75% with Operating Profit Margin at 0.05%, Pretax Profit Margin comes in at 0.06%, and Net Profit Margin reading is 0.06%. To continue investigating profitability, this company’s Return on Assets is posted at 0.06, Equity is 0.25 and Total Capital is 0.06. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 1.92.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 37.58 points at the first support level, and at 36.75 for the second support level. However, for the 1st resistance point, the stock is sitting at 39.01, and for the 2nd resistance point, it is at 39.61.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Hims & Hers Health Inc [NYSE:HIMS] is 1.88. Also, the Quick Ratio is 1.64, while the Cash Ratio stands at 0.77. Considering the valuation of this stock, the price to sales ratio is 3.95, the price to book ratio is 15.04 and price to earnings (TTM) ratio is 70.99.
Transactions by insiders
Recent insider trading involved Boughton Soleil, Chief Legal Officer, that happened on Nov 24 ’25 when 2631.0 shares were sold. Officer, Boughton Soleil completed a deal on Nov 24 ’25 to buy 2631.0 shares. Meanwhile, Chief Financial Officer Okupe Oluyemi sold 23187.0 shares on Nov 17 ’25.
